INTS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.072400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.910600E-01
Normal-vs-Stage2
3.730400E-01
Normal-vs-Stage3
1.483560E-01
Normal-vs-Stage4
4.959200E-01
Stage1-vs-Stage2
3.367200E-01
Stage1-vs-Stage3
1.166450E-01
Stage1-vs-Stage4
4.972800E-01
Stage2-vs-Stage3
1.530580E-01
Stage2-vs-Stage4
8.549200E-01
Stage3-vs-Stage4
3.143600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.172200E-01
Normal-vs-AfricanAmerican
7.447000E-01
Normal-vs-Asian
2.443800E-01
Caucasian-vs-AfricanAmerican
3.141800E-01
Caucasian-vs-Asian
3.249400E-01
AfricanAmerican-vs-Asian
2.212800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.188600E-01
Normal-vs-Female
5.382800E-01
Male-vs-Female
2.296000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.034800E-01
Normal-vs-Age(41-60Yrs)
5.754800E-01
Normal-vs-Age(61-80Yrs)
3.589600E-01
Normal-vs-Age(81-100Yrs)
3.950000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.278800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.846800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.888200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.103600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.687800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.894400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.144230E-01
Normal-vs-Daily Drinker
7.512300E-02
Normal-vs-Weekly Drinker
2.491200E-01
Normal-vs-Occasional Drinker
5.315600E-01
Normal-vs-Social Drinker
7.921200E-01
Non Drinker-vs-Daily Drinker
6.005600E-01
Non Drinker-vs-Weekly Drinker
9.626200E-01
Non Drinker-vs-Occasional Drinker
1.728970E-01
Non Drinker-vs-Social Drinker
2.390500E-02
Daily Drinker-vs-Weekly Drinker
6.657200E-01
Daily Drinker-vs-Occasional Drinker
9.812400E-02
Daily Drinker-vs-Social Drinker
1.239760E-02
Weekly Drinker-vs-Occasional Drinker
3.388000E-01
Weekly Drinker-vs-Social Drinker
1.033830E-01
Occasional Drinker-vs-Social Drinker
4.750200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.103010E-01
Normal-vs-Grade 2
1.259590E-01
Normal-vs-Grade 3
3.939900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.312000E-01
Grade 1-vs-Grade 3
8.969000E-01
Grade 1-vs-Grade 4
1.103010E-01
Grade 2-vs-Grade 3
2.901600E-01
Grade 2-vs-Grade 4
1.259590E-01
Grade 3-vs-Grade 4
3.939900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.811640E-01
Normal-vs-NonDiabetic
3.883400E-01
Diabetic-vs-NonDiabetic
2.283400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.242800E-01
Normal-vs-NoPancreatitis
3.808000E-01
Pancreatitis-vs-NoPancreatitis
3.429200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.400400E-01
Normal-vs-N1
2.789200E-01
N0-vs-N1
3.653200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.699600E-01
Normal-vs-TP53-NonMutant
8.905600E-01
TP53-Mutant-vs-TP53-NonMutant
9.287800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
